Edgar Filing: Otonomy, Inc.

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â Lichter Jay

2. Date of Event Requiring Statement (Month/Day/Year)
08/12/2014

3. Issuer Name and Ticker or Trading Symbol
Otonomy, Inc. [OTIC]

(Last)

(First)

(Middle)

C/O AVALON VENTURES,Â 1134 KLINE STREET

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

LA JOLLA,Â CAÂ 92037

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	8,532	I	See footnote ⁽¹⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series A Preferred Stock	Â ⁽²⁾	Â ⁽²⁾	Common Stock	740,057	$ ⁽²⁾	I	See footnote ⁽¹⁾
Series B Preferred Stock	Â ⁽³⁾	Â ⁽³⁾	Common Stock	175,889	$ ⁽³⁾	I	See footnote ⁽¹⁾
Series C Preferred Stock	Â ⁽³⁾	Â ⁽³⁾	Common Stock	484,691	$ ⁽³⁾	I	See footnote ⁽¹⁾
Series C Preferred Stock	Â ⁽³⁾	Â ⁽³⁾	Common Stock	568,828	$ ⁽³⁾	I	See footnote ⁽⁴⁾
Series D Preferred Stock	Â ⁽³⁾	Â ⁽³⁾	Common Stock	136,770	$ ⁽³⁾	I	See footnote ⁽⁴⁾
Series A Preferred Stock Warrant (right to buy)	Â ⁽⁵⁾	11/04/2018	Series A Preferred Stock ⁽²⁾	6,432	$ 31.092	I	See footnote ⁽¹⁾
Series A Preferred Stock Warrant (right to buy)	Â ⁽⁵⁾	12/08/2018	Series A Preferred Stock ⁽²⁾	6,432	$ 31.092	I	See footnote ⁽¹⁾
Series A Preferred Stock Warrant (right to buy)	Â ⁽⁵⁾	01/14/2019	Series A Preferred Stock ⁽²⁾	6,432	$ 31.092	I	See footnote ⁽¹⁾
Series A Preferred Stock Warrant (right to buy)	Â ⁽⁵⁾	04/13/2019	Series A Preferred Stock ⁽²⁾	6,432	$ 31.092	I	See footnote ⁽¹⁾
Series A Preferred Stock Warrant (right to buy)	Â ⁽⁵⁾	07/01/2019	Series A Preferred Stock	6,432	$ 31.092	I	See footnote ⁽¹⁾
Series A Preferred Stock Warrant (right to buy)	Â ⁽⁵⁾	10/08/2019	Series A Preferred Stock ⁽²⁾	6,432	$ 31.092	I	See footnote ⁽¹⁾
Series A Preferred Stock Warrant (right to buy)	Â ⁽⁵⁾	12/15/2019	Series A Preferred Stock ⁽²⁾	6,432	$ 31.092	I	See footnote ⁽¹⁾
Series A Preferred Stock Warrant (right to buy)	Â ⁽⁵⁾	01/22/2020	Series A Preferred Stock ⁽²⁾	6,432	$ 31.092	I	See footnote ⁽¹⁾
Series A Preferred Stock Warrant (right to buy)	Â ⁽⁵⁾	04/01/2020	Series A Preferred Stock ⁽²⁾	6,432	$ 31.092	I	See footnote ⁽¹⁾
Series A Preferred Stock Warrant (right to buy)	Â ⁽⁵⁾	05/28/2020	Series A Preferred Stock ⁽²⁾	6,432	$ 31.092	I	See footnote ⁽¹⁾
Series C Preferred Stock Warrant (right to buy)	Â ⁽⁵⁾	08/18/2014	Series C Preferred Stock ⁽³⁾	48,539	$ 8.79	I	See footnote ⁽¹⁾
Series C Preferred Stock Warrant (right to buy)	Â ⁽⁵⁾	08/18/2014	Series C Preferred Stock ⁽³⁾	42,472	$ 8.79	I	See footnote ⁽¹⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Lichter Jay C/O AVALON VENTURES 1134 KLINE STREET LA JOLLA,Â CAÂ 92037	Â X	Â X	Â	Â

Signatures

/s/ Jay Lichter		08/12/2014
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The reported securities are held of record by Avalon Ventures VIII, L.P. ("Avalon VIII LP"). The Reporting Person is a managing director of Avalon Ventures VIII GP, LLC ("Avalon VIII GP"), the general partner of Avalon VIII LP, and disclaims beneficial ownership of the securities held by Avalon VIII LP except to the extent of any pecuniary interest therein.
(2)	The Series A Convertible Preferred Stock shall automatically convert into Common Stock on a 2.193204365 to one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date.
(3)	Each of the Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock shall automatically convert into Common Stock on a one for one basis immediately prior to the completion of the Issuer's initial public offering of common stock and has no expiration date.
(4)	The reported securities are held of record by Avalon Ventures X, L.P. ("Avalon X LP"). The Reporting Person is a managing director of Avalon Ventures X GP, LLC ("Avalon X GP"), the general partner of Avalon X LP, and disclaims beneficial ownership of the securities held by Avalon X LP except to the extent of any pecuniary interest therein.
(5)	The warrants are immediately exercisable.
Â Remarks: ExhibitÂ 24Â -Â PowerÂ ofÂ Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.